1887

oa SA Pharmaceutical Journal - Ethosuximide in a patient with myoclonic astatic seizures : forum

 

Abstract

Myoclonic astatic epilepsy is currently treated with valproic acid as the first line treatment of choice. However, this is based on expert opinion due to the paucity of good evidence1. Described here is the case of a 7-year-old boy with myoclonic astatic epilepsy, whose seizures could not be controlled on valproic acid monotherapy, and who rapidly improved with ethosuximide as add-on therapy.

Loading

Article metrics loading...

/content/mp_sapj/83/3/EJC189538
2016-01-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error